Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.0%

1 terminated out of 25 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

28%

7 trials in Phase 3/4

Results Transparency

38%

6 of 16 completed with results

Key Signals

6 with results94% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (4)
P 1 (3)
P 2 (5)
P 3 (5)
P 4 (2)

Trial Status

Completed16
Unknown3
Recruiting3
Terminated1
Active Not Recruiting1
Not Yet Recruiting1

Trial Success Rate

94.1%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07479238Not Yet Recruiting

Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy

NCT06995651Phase 1RecruitingPrimary

Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis

NCT01851694Not ApplicableRecruiting

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

NCT04731272Phase 2Recruiting

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

NCT01144507Completed

Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis

NCT02979340Completed

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

NCT05466838Not ApplicableActive Not RecruitingPrimary

PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled Trial

NCT03551691Phase 2CompletedPrimary

Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)

NCT05700604Completed

Hypoglycemia and Glucagon Response in CF

NCT01879228Not ApplicableCompleted

Effect of Chronic Incretin-based Therapy in Cystic Fibrosis

NCT03450772Phase 3UnknownPrimary

Equivalence Study to Compare Two Strengths of Creon in China

NCT02985801Phase 1TerminatedPrimary

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

NCT03279653Unknown

Pancreatic Exocrine Insufficiency After Bariatric Surgery

NCT00763412Not ApplicableCompleted

Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis

NCT00880100Phase 3Completed

Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

NCT00513682Phase 3Completed

Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)

NCT01710644Phase 1CompletedPrimary

Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

NCT00095732Phase 2Completed

Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency

NCT01988350CompletedPrimary

Pancreatic Insufficiency Secondary to Tobacco Exposure

NCT00406536Phase 2Completed

Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI

Scroll to load more

Research Network

Activity Timeline